| Regine Tillmanns, MD | |
|
830 Main St, Suite 2, Melrose, MA 02176-2711 | |
| (781) 662-3141 | |
| (781) 662-2210 |
| Full Name | Regine Tillmanns |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 32 Years |
| Location | 830 Main St, Melrose, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417981960 | NPI | - | NPPES |
| 2148030 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 234443 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Partners Healthcare At Home - Home Care | Waltham, MA | Home health agency |
| Home Health Of Haverhill | Lawrence, MA | Home health agency |
| North Shore Medical Center - | Salem, MA | Hospital |
| Melrosewakefield Healthcare | Melrose, MA | Hospital |
| Massachusetts General Hospital | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mass General Brigham Community Physicians Inc | 1759273436 | 297 |
News Archive
Roche and GlaxoSmithKline announced today the submission of a Marketing Authorisation Application to the European authorities for a novel, once-monthly oral formulation of their new bisphosphonate, Bonviva (ibandronate), for the treatment of postmenopausal osteoporosis.
ChromaDex Corporation, a natural products chemistry company which provides novel and innovative ingredients to the dietary supplement, food, beverage and cosmetic markets, announced today The Frost Group, LLC, led by Miami entrepreneur and billionaire Dr. Phillip Frost, has agreed to make an investment in ChromaDex.
The number of teens taking and overdosing from benzodiazepines, commonly prescribed anxiety medications, has risen dramatically over the past decade, according to a national study coauthored by Rutgers researchers.
Vaccinating infants with a single fractional dose of inactivated poliovirus is an effective and more affordable alternative to using multiple full doses, report researchers in the New England Journal of Medicine.
› Verified 6 days ago
| Entity Name | Hallmark Health Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770563900 PECOS PAC ID: 4385638782 Enrollment ID: O20040409000006 |
News Archive
Roche and GlaxoSmithKline announced today the submission of a Marketing Authorisation Application to the European authorities for a novel, once-monthly oral formulation of their new bisphosphonate, Bonviva (ibandronate), for the treatment of postmenopausal osteoporosis.
ChromaDex Corporation, a natural products chemistry company which provides novel and innovative ingredients to the dietary supplement, food, beverage and cosmetic markets, announced today The Frost Group, LLC, led by Miami entrepreneur and billionaire Dr. Phillip Frost, has agreed to make an investment in ChromaDex.
The number of teens taking and overdosing from benzodiazepines, commonly prescribed anxiety medications, has risen dramatically over the past decade, according to a national study coauthored by Rutgers researchers.
Vaccinating infants with a single fractional dose of inactivated poliovirus is an effective and more affordable alternative to using multiple full doses, report researchers in the New England Journal of Medicine.
› Verified 6 days ago
| Entity Name | Mass General Brigham Community Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548638265 PECOS PAC ID: 1759273436 Enrollment ID: O20151215000536 |
News Archive
Roche and GlaxoSmithKline announced today the submission of a Marketing Authorisation Application to the European authorities for a novel, once-monthly oral formulation of their new bisphosphonate, Bonviva (ibandronate), for the treatment of postmenopausal osteoporosis.
ChromaDex Corporation, a natural products chemistry company which provides novel and innovative ingredients to the dietary supplement, food, beverage and cosmetic markets, announced today The Frost Group, LLC, led by Miami entrepreneur and billionaire Dr. Phillip Frost, has agreed to make an investment in ChromaDex.
The number of teens taking and overdosing from benzodiazepines, commonly prescribed anxiety medications, has risen dramatically over the past decade, according to a national study coauthored by Rutgers researchers.
Vaccinating infants with a single fractional dose of inactivated poliovirus is an effective and more affordable alternative to using multiple full doses, report researchers in the New England Journal of Medicine.
› Verified 6 days ago
| Entity Name | Mass General Brigham Community Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891356374 PECOS PAC ID: 1759273436 Enrollment ID: O20191105001452 |
News Archive
Roche and GlaxoSmithKline announced today the submission of a Marketing Authorisation Application to the European authorities for a novel, once-monthly oral formulation of their new bisphosphonate, Bonviva (ibandronate), for the treatment of postmenopausal osteoporosis.
ChromaDex Corporation, a natural products chemistry company which provides novel and innovative ingredients to the dietary supplement, food, beverage and cosmetic markets, announced today The Frost Group, LLC, led by Miami entrepreneur and billionaire Dr. Phillip Frost, has agreed to make an investment in ChromaDex.
The number of teens taking and overdosing from benzodiazepines, commonly prescribed anxiety medications, has risen dramatically over the past decade, according to a national study coauthored by Rutgers researchers.
Vaccinating infants with a single fractional dose of inactivated poliovirus is an effective and more affordable alternative to using multiple full doses, report researchers in the New England Journal of Medicine.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Regine Tillmanns, MD 830 Main St, Suite 2, Melrose, MA 02176-2711 Ph: (781) 662-3141 | Regine Tillmanns, MD 830 Main St, Suite 2, Melrose, MA 02176-2711 Ph: (781) 662-3141 |
News Archive
Roche and GlaxoSmithKline announced today the submission of a Marketing Authorisation Application to the European authorities for a novel, once-monthly oral formulation of their new bisphosphonate, Bonviva (ibandronate), for the treatment of postmenopausal osteoporosis.
ChromaDex Corporation, a natural products chemistry company which provides novel and innovative ingredients to the dietary supplement, food, beverage and cosmetic markets, announced today The Frost Group, LLC, led by Miami entrepreneur and billionaire Dr. Phillip Frost, has agreed to make an investment in ChromaDex.
The number of teens taking and overdosing from benzodiazepines, commonly prescribed anxiety medications, has risen dramatically over the past decade, according to a national study coauthored by Rutgers researchers.
Vaccinating infants with a single fractional dose of inactivated poliovirus is an effective and more affordable alternative to using multiple full doses, report researchers in the New England Journal of Medicine.
› Verified 6 days ago
Fadel Bofarrag, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 585 Lebanon St, Melrose, MA 02176 Phone: 800-424-3672 Fax: 314-434-5939 | |
Prava Karki, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 585 Lebanon St, Melrose, MA 02176 Phone: 781-979-3000 | |
Mike H Summerer, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 585 Lebanon Street, Hallmark Health System, Melrose, MA 02176 Phone: 781-979-3342 | |
Mohender S Maan, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 585 Lebanon St, Melrose Wakefield Hospital, Melrose, MA 02176 Phone: 781-979-3000 | |
Dr. Erica L Brooks, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 50 Rowe St, Suite 600, Melrose, MA 02176 Phone: 781-979-3440 Fax: 781-979-0258 | |
Dr. Raj P. Shah, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 585 Lebanon St, Melrose, MA 02176 Phone: 860-305-6911 | |
Ronald P Sen, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 50 Tremont St, #109, Melrose, MA 02176 Phone: 781-662-3310 Fax: 781-662-6403 |